Pacific Biosciences of California (NASDAQ:PACB) & Disaboom (OTCMKTS:MEDH) Financial Contrast

Disaboom (OTCMKTS:MEDH) and Pacific Biosciences of California (NASDAQ:PACB) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, dividends, profitability, earnings, valuation, institutional ownership and analyst recommendations.

Profitability

This table compares Disaboom and Pacific Biosciences of California’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Disaboom	5.91%	N/A	N/A
Pacific Biosciences of California	-325.02%	-101.49%	-18.83%

Analyst Ratings

This is a summary of recent ratings and price targets for Disaboom and Pacific Biosciences of California, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Disaboom	0	0	0	0	0.00
Pacific Biosciences of California	1	3	3	0	2.29

Pacific Biosciences of California has a consensus price target of $2.08, indicating a potential downside of 19.25%. Given Pacific Biosciences of California’s stronger consensus rating and higher possible upside, analysts plainly believe Pacific Biosciences of California is more favorable than Disaboom.

Volatility & Risk

Disaboom has a beta of 1.5, indicating that its share price is 50% more volatile than the S&P 500. Comparatively, Pacific Biosciences of California has a beta of 2.2, indicating that its share price is 120% more volatile than the S&P 500.

Earnings and Valuation

This table compares Disaboom and Pacific Biosciences of California”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Disaboom	$890,000.00	0.54	-$170,000.00	N/A	N/A
Pacific Biosciences of California	$154.58 million	5.04	-$309.85 million	($2.20)	-1.17

Disaboom has higher earnings, but lower revenue than Pacific Biosciences of California.

Summary

Pacific Biosciences of California beats Disaboom on 6 of the 10 factors compared between the two stocks.

About Disaboom

Dazed, Inc. focuses on retail, distribution, hospitality, licensing, and franchising of portfolio of counterculture brands. The company was formerly known as MedX Holdings, Inc. and changed its name to Dazed, Inc. in October 2022. Dazed, Inc. was founded in 2004 and is based in Cheyenne, Wyoming.

About Pacific Biosciences of California

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solution to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-red sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. In addition, it provides revio system + sequel systems which conduct, monitor, and analyze single-molecule biochemical reactions in real time; SBB short-read sequencing; onso instrument conducts, monitors, and analyzes SBB biochemical reactions; and SBB consumable, including flow cells, clustering, and sequencing reagent kits. The company serves academic and governmental research institutions; commercial testing and service laboratories; genome centers; public health labs, hospitals and clinical research institutes, and contract research organizations; pharmaceutical companies; and agricultural companies. It markets its products through a sales force and distribution partners in Asia, Australia, Europe, the Middle East, Africa, and Latin America. It has a development and commercialization agreement with Invitae Corporation; and a collaboration with Radboud University Medical to explore genetic causes of rare and genetic diseases. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.